Using nanomagnets composites and conductive yarn, scientists have invented a smart textile that can sense and measure body movements—from muscles flexing to veins pulsing.
Leaders from 12 nuclear medicine organizations around the world have issued a white paper about the challenges and opportunities in theranostics education.
Low-level laser therapy and associated photobiomodulation is the most effective of the known treatments for tinnitus, according to a study comparing the main therapies in current use, conducted by Brazilian scientists affiliated with the Optics and Photonics Research Center (CEPOF).
There are few effective treatments for acute stroke, and many patients aren’t eligible for them. An innovative pilot study from UCLA Health found promising results for a new potential treatment: highly targeted electrical stimulation to the affected brain area.
Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—convened a policy summit to examine how geography impacts cancer outcomes.
Researchers from The University of Texas Health Science Center at San Antonio, working with collaborators in five countries, today revealed that the capacity to resist or recover from infections and other sources of inflammatory stress — called “immune resilience” — differs widely among individuals.
In situ bioprinting, which involves 3D printing biocompatible structures and tissues directly within the body, has seen steady progress over the past few years.
Treating children with cardiomyopathy should be personalized based on the root cause, symptoms and progression of the condition in each child , according to a new American Heart Association scientific statement published today in the Association’s flagship, peer-reviewed journal Circulation.
Treatment efficacy for a broad range of chronic diseases does not differ depending on patients’ comorbidities, according to a new study publishing June 6th in the open access journal PLOS Medicine by David McAllister of the University of Glasgow, UK, and colleagues.
Scientists from the UCLA Jonsson Comprehensive Cancer Center have developed a new method to bioprint miniature tumor organoids that are designed to mimic the function and architecture of real tumors. The improved process allows researchers to use an advanced imaging method to study and analyze individual organoids in great detail, which can help researchers identify personalized treatments for people with rare or hard-to-treat cancers.
The accuracy of prostate-specific antigen (PSA) screening for prostate cancer can be improved by accounting for genetic factors that cause changes in PSA levels that are not associated with cancer, according to a multi-center study led by UC San Francisco and Stanford University, publishing June 1 in Nature Medicine.
Para vislumbrar o futuro da medicina, conheça o Centro de Medicina Individualizada de última geração da Mayo Clinic. No Centro, médicos, pesquisadores, cientistas de dados, engenheiros de inteligência artificial e especialistas em bioética estão trabalhando em estreita colaboração para investigar os massivos conjuntos de dados “ômicos”.
Para vislumbrar el futuro de la medicina, ingrese al Centro de Medicina Personalizada de última generación en Mayo Clinic. Allí, médicos, investigadores, analistas de datos, ingenieros de inteligencia artificial y bioéticos trabajan a la par para investigar los inmensos conjuntos de datos de las ómicas.
لتحصل على لمحة عن مستقبل الطب، ما عليك إلا أن تخطو داخل مركز مايو كلينك المتطور للطب الشخصي. فهناك يعمل الأطباء والباحثون وعلماء البيانات ومهندسو الذكاء الاصطناعي واختصاصيو أخلاقيات علم البيولوجيا جنبًا إلى جنب لفحص مجموعات بيانات "أوميكس" الضخمة. هذا النهج المبتكر هو نتاج مشاركة آلاف المرضى في الدراسات البحثية والتجارب السريرية المرتبطة بأوميكس.
Investigators from Cedars-Sinai Cancer, working in collaboration with colleagues in Colorado and the Netherlands, have identified a specific type of bladder cancer most likely to resist first-line treatment.
A gene regulating the F-Box and WD Repeat Domain Containing 7 (FBXW7) protein is frequently mutated or deleted in various types of human cancer, including gynecological cancers.
Skin cancer is the most prevalent form of cancer in the United States, with over 5 million cases diagnosed annually. The Centers for Disease Control and Prevention reports that melanoma alone accounts for more than 8,000 deaths each year. Thankfully, skin cancer is highly preventable, making it crucial to prioritize protection. Below are some of the latest headlines in the Dermatology channel.
El Departamento de Biomedicina Computacional de Cedars-Sinai recientemente refinó su enfoque en el avance de la inteligencia artificial y el aprendizaje automatizado al establecer el Centro de Investigación y Educación de Inteligencia Artificial.
EXI – the Software as a Medical Device (SaMD) that delivers personalized physical activity prescription and behavior change support for people with long-term health conditions – has unveiled its first Exercise is Medicine® (EIM) deployment alliances.
Freedom Aquatic & Fitness Center (FAFC) – located onsite at George Mason University Science & Technology campus in Manassus, Virginia, with a specialist team that delivers EIM in the community and via health provider referrals – and Logan Health, a Montana healthcare system offering EIM programs through its medical fitness center in Kalispell, Montana, will be the first facilities to deploy Exercise is Medicine® using EXI’s digital platform.
Eimear Kenny, PhD, had just completed undergrad and was working in her first computational genomics job more than 20 years ago when scientists announced the first (nearly) complete sequencing of the human genome—what was considered at the time to be the fundamental blueprint for all humans. The Human Genome Project aimed to map the entire genome in an effort to accelerate the diagnosis and eventual treatment of common and rare diseases.
May is a month to recognize the importance of cancer research, with both Brain Tumor Awareness Month and National Cancer Research Month taking center stage. Virginia Tech’s Fralin Biomedical Research Institute at VTC is dedicated to advancing our understanding of cancer and developing new ways to treat and prevent it. Teams of investigators are working to uncover the molecular mechanisms that drive cancer growth, migration, and metastasis.
An exhaustive cost-benefit analysis of population genetic testing published in Annals of Internal Medicine concludes with a recommendation to U.S. health policymakers to adopt routine testing of adults ages 40 and under for three genetic conditions posing high risk of life-threatening illness.
Researchers from the University of California, Irvine have developed a DNA enzyme – or DNAzyme – that can distinguish between two RNA strands inside a cell and cut the disease-associated strand while leaving the healthy strand intact. This breakthrough “gene silencing” technology could revolutionize the development of DNAzymes for treating cancer, infectious diseases and neurological disorders.
Mayo Clinic Platform is expanding its distributed data network, Mayo Clinic Platform_Connect, to include Hospital Israelita Albert Einstein in Brazil, Sheba Medical Center in Israel and University Health Network (UHN) in Canada, joining Mercy, Connect’s first member. The first-of-its-kind global alliance establishes a data-sharing network that transcends language barriers and accelerates AI-based solutions by using current data science and years of clinical data to create better patient outcomes around the world.
University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today that Bradley A. Maron, MD, Associate Professor of Medicine at Brigham & Women’s Hospital (BWH) and Harvard Medical School (HMS), and Co-Director of the Pulmonary Vascular Disease Center at the VA Boston Healthcare System, has been appointed Co-Director of the UMB’s new Institute for Health Computing (UM-IHC), Director of Scientific Operations for the UM-IHC at UMSOM, as well as Senior Associate Dean for Precision Medicine at the UMSOM, effective May 1, 2023.
Ann & Robert H. Lurie Children’s Hospital of Chicago is the first in Illinois to receive designation as a NORD Rare Disease Center of Excellence, becoming one of 40 U.S. academic medical centers selected to be a part of the first-of-it-kind national network of U.S. medical institutions dedicated to diagnosing, treating, and researching all rare diseases. The network is led by the National Organization for Rare Disorders (NORD) and is designed to foster knowledge sharing between rare disease experts across the country to help meet the unmet needs of more than 25 million Americans living with a rare disease.
Today, the National Organization for Rare Disorders (NORD) announced the addition of nine new Rare Disease Centers of Excellence, bringing the total number of medical centers in this network to 40 on the day of the 40th anniversary of NORD's founding.
Cleveland Clinic has been designated a Rare Disease Center of Excellence by the National Organization for Rare Disorders (NORD). The new Cleveland Clinic Center for Rare Diseases is one of 40 U.S. academic medical centers selected to join the first-of-it-kind national network dedicated to diagnosing, treating and researching all rare diseases.
Physician-scientist Paul Noble, MD, chair of the Department of Medicine at Cedars-Sinai, was named president-elect of the Association of American Physicians (AAP) at the group's annual meeting in Chicago on April 22.
Hackensack Meridian Health, New Jersey’s largest and most comprehensive health network, announced that nationally recognized orthopedic surgeons are partnering with the network to launch Orthopedic Specialists of New Jersey.
Multiple myeloma is a rare blood cancer caused by the uncontrolled multiplication of abnormal plasma cells. These plasma cells are a special type of white blood cells that play an important role in the immune system by producing essential antibodies in the bone marrow and lymph nodes.
In a new translational study from UCLA Jonsson Comprehensive Cancer Center, researchers analyzed genetic changes in the organs of recently deceased patients to understand how metastatic cutaneous melanoma spreads in those who had initially benefited from precision therapies.
Researchers at Cornell University have developed a knitted wearable tool to treat hand edema – swelling caused by excess fluid accumulation, from injury or disease – that can be personalized and used in the comfort of one’s own home.
Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer’s disease.
The time period in which muscles heal after injury may depend on biological sex, and applying personalized treatment may help optimize recovery, according to a new study.
Cedars-Sinai investigators are developing a novel way to treat amyotrophic lateral sclerosis (ALS) and retinitis pigmentosa using engineered stem cells that may eventually lead to personalized treatments.
To address the unique needs of today’s patients with breast disease and breast cancer, the American College of Surgeons (ACS) National Accreditation Program for Breast Centers (NAPBC) has released new standards for accredited centers that place patients at the center of the framework.
Black and socioeconomically disadvantaged patients with peripheral arterial disease have more severe symptoms before bypass surgery – and are at greater risk for amputation and other complications after the procedure, a new study shows. Researchers say health care providers need to recognize the vulnerability of certain subgroups to adverse outcomes and be on alert for early signs and symptoms of PAD to manage patients accordingly.
Cedars-Sinai Cancer’s commitment to convergent science—the deep melding of computational, physical engineering and biological sciences—is evident throughout its 2023 Annual Report.
El uso de la prescripción de opioides puede tener un efecto negativo en la función cognitiva de los adultos mayores de acuerdo con un estudio reciente de Mayo Clinic publicado en la revista de la Sociedad Estadounidense de Geriatría.
A study has found that ketamine may be more helpful in preventing postoperative pain among a subset of patients with a higher tendency toward central sensitization as measured by TSP (temporal summation of pain).
A new study led by researchers at The University of Texas MD Anderson Cancer Center discovered that co-occurring mutations in three tumor suppressor genes – KEAP1, SMARCA4 and CDKN2A – are linked with poor clinical outcomes in patients with KRAS G12C-mutant non-small cell lung cancer (NSCLC) treated with the KRAS G12C inhibitors adagrasib or sotorasib.
A new CALM mutation causes lethal arrhythmia in humans. Using cardiomyocytes -- or heart muscle cells -- from human iPS cell and recombinant calmodulin proteins, the group studied catecholaminergic polymorphic ventricular tachycardia -- or CPVT, a rare and life-threatening genetic condition. The team was able to reproduce severe arrhythmia in patient-derived iPS cell models of exercise-induced CPVT with calmodulin mutations.
Receber uma massagem de um robô pode parecer algo saído de uma história de ficção científica, mas essa pode ser uma realidade em um futuro não muito distante.
Recibir un masaje de parte de un robot puede parecer algo salido de un cuento de ciencia ficción, pero podría ser una realidad en un futuro no tan lejano.